Back to search

Article

Evidence of Tenofovir Resistance in Chronic Hepatitis B Virus (HBV) Infection: An Observational Case Series of South African Adults

2020-03-20

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction</h4> Tenofovir disoproxil fumarate (TDF) is widely recommended for treatment of chronic hepatitis B virus (HBV) infection because it is safe, affordable and has a high genetic barrier to resistance. TDF resistance associated mutations (RAMs) have been reported, but data are limited, particularly for Africa. We set out to identify RAMs in individuals with detectable HBV viraemia o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
394ecb02-c287-58c8-a6d2-98d42e0049f7
DOI
10.1101/2020.03.18.20038216
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evidence of Tenofovir Resistance in Chronic Hepatitis B Virus (HBV) Infection: An Observational Case Series of South African AdultsDOI 10.1101/2020.03.18.20038216
Select a neighboring publication to make it the new centre.